Physician profile
Lupe Guerra
NPI 1205319019
$15,711.66
in general payments reported to CMS, 2019-2025
60 companies · $5,523 in 2025
The $5,523 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,598 · 2023: $4,663 · 2024: $3,928 · 2025: $5,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $67.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,046.43 |
| Education | $67.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $1,319.27 | 2022-2025 | Rystiggo, Briviact, Nayzilam |
| Neurocrine Biosciences, INC. | $1,014.86 | 2022-2025 | Ingrezza, Ongentys |
| Acadia Pharmaceuticals INC | $847.40 | 2022-2025 | Nuplazid |
| Pfizer INC. | $836.87 | 2023-2025 | |
| Abbvie INC. | $835.02 | 2022-2025 | |
| Mdd US Operations, LLC | $833.35 | 2023-2025 | Gocovri, Gocovri, Apokyn |
| Emd Serono, INC. | $736.74 | 2023-2025 | Mavenclad, Mavenclad |
| Teva Pharmaceuticals USA, INC. | $709.85 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Argenx US, INC. | $686.07 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Sk Life Science, INC. | $604.44 | 2022-2025 | Xcopri |
| Csl Behring | $515.62 | 2023-2025 | Hizentra |
| Biogen, INC. | $480.95 | 2022-2025 | Vumerity, Tysabri, Plegridy |
| Alexion Pharmaceuticals, INC. | $479.18 | 2022-2025 | Ultomiris, Soliris |
| Takeda Pharmaceuticals U.S.A., INC. | $406.26 | 2023-2025 | Hyqvia |
| Lilly USA, LLC | $399.95 | 2022-2025 | Amyvid, Emgality, Kisunla |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $366.23 | 2022-2025 | Crexont, Rytary, Lyvispah |
| Eisai INC. | $311.51 | 2023-2025 | |
| Genentech USA, INC. | $293.22 | 2022-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Supernus Pharmaceuticals, INC. | $272.54 | 2022-2025 | Qelbree |
| Lundbeck LLC | $231.62 | 2023-2025 | Vyepti, Rexulti |
| Mallinckrodt Hospital Products INC. | $223.26 | 2022-2025 | Acthar |
| Horizon Therapeutics Plc | $223.14 | 2022-2023 | Uplizna |
| Impel Pharmaceuticals INC. | $203.25 | 2023 | Trudhesa |
| Tg Therapeutics, INC. | $194.05 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $192.90 | 2023-2025 | Rexulti, Nuedexta |
| Tanabe Pharma America, INC. | $183.33 | 2022-2024 | |
| Amgen INC. | $182.38 | 2022-2025 | Uplizna |
| Sumitomo Pharma America, INC. | $180.13 | 2023-2024 | Aptiom |
| Celgene Corporation | $169.95 | 2023 | Zeposia |
| Neurelis, INC. | $169.00 | 2022-2025 | Valtoco |
| Merz Pharmaceuticals, LLC | $156.61 | 2023-2025 | Xeomin, Inbrija |
| Grifols USA, LLC | $148.93 | 2023-2025 | Gamunex-C |
| Ge Healthcare | $142.61 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $123.10 | 2022-2025 | |
| Janssen Biotech, INC. | $113.37 | 2025 | |
| Banner Life Sciences, LLC | $107.17 | 2022-2023 | |
| Catalyst Pharmaceuticals, INC. | $75.92 | 2024 | |
| Avion Pharmaceuticals | $72.38 | 2022-2023 | Dhivy |
| Impel Pharmaceuticals LLC | $70.61 | 2025 | Trudhesa |
| Corium, LLC | $62.46 | 2022-2023 | Adlarity |
| Boston Scientific Corporation | $57.45 | 2022-2024 | |
| Azurity Pharmaceuticals, INC. | $40.26 | 2024-2025 | Zonisade, Horizant |
| Averitas Pharma INC. | $39.95 | 2023-2025 | Qutenza |
| Silk Road Medical, INC. | $33.44 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| C2n Diagnostics, LLC | $32.69 | 2025 | Precivityad2 |
| Avadel Cns Pharmaceuticals, LLC | $29.92 | 2025 | Lumryz |
| E.R. Squibb & Sons, L.L.C. | $28.29 | 2023 | Zeposia |
| Sunovion Pharmaceuticals INC. | $28.09 | 2022 | |
| Jazz Pharmaceuticals INC. | $27.13 | 2022 | |
| Atland Pharmaceuticals, LLC | $25.47 | 2024 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Grt US Holding, INC. | $24.66 | 2022 | |
| Immedica Pharma US, INC. | $24.33 | 2024 | |
| Kyowa Kirin, INC. | $21.44 | 2022 | |
| Axsome Therapeutics, INC. | $20.82 | 2025 | Sunosi |
| Aucta Pharmaceuticals, INC. | $18.37 | 2025 | Motpoly Xr |
| Janssen Pharmaceuticals, INC | $17.90 | 2025 | |
| Insightec,INC | $17.09 | 2022 | |
| Acorda Therapeutics, INC | $16.72 | 2023 | Ampyra, Inbrija |
| Genzyme Corporation | $16.64 | 2022 | |
| Tonix Medicines, INC. | $15.50 | 2024 | Zembrace Symtouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lupe Guerra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.